Table 1.
A Summary Shows the Baseline Information of Patients
| Variables | Total (n=119) | Survival (n=101) | Mortality (n=18) |
|---|---|---|---|
| Sex, n(%) | |||
| Male | 62 (52.10) | 53 (52.48) | 9 (50.00) |
| Female | 57 (47.90) | 48 (47.52) | 9 (50.00) |
| Age (year), Mean±SD | 42.13±19.21 | 40.26±18.72 | 52.61±19.02 |
| Weight (kg), Mean±SD | 52.57±7.96 | 52.64±8.13 | 52.08±6.93 |
| Smoking, n(%) | 38 (31.93) | 32 (31.68) | 6 (33.33) |
| Drinking, n(%) | 31 (26.05) | 28 (27.72) | 3 (16.67) |
| Comorbidities, n(%) | 50 (42.02) | 40 (39.60) | 10 (55.56) |
| MRC grade, n(%) | |||
| Grade I | 83 (69.74) | 75 (75.26) | 8 (44.44) |
| Grade II | 15 (12.61) | 11 (10.89) | 4 (22.22) |
| Grade III | 21 (17.65) | 15 (14.85) | 6 (33.33) |
| NAT2 genotype, n(%) | |||
| FA | 34 (28.57) | 30 (29.70) | 4 (22.22) |
| IA | 73 (61.35) | 62 (61.39) | 11 (61.11) |
| SA | 12 (10.08) | 9 (8.91) | 3 (16.67) |
| Diagnostic of TBM, n(%) | |||
| Definite | 41 (34.46) | 34 (33.66) | 7 (38.89) |
| Probable | 42 (35.29) | 31 (30.69) | 5 (27.78) |
| Possible | 36 (30.25) | 36 (35.64) | 6 (33.33) |
| INH Dose, n(%) | |||
| 300 mg/day | 32 (26.89) | 23 (22.77) | 9 (50.00) |
| 600 mg/day | 87 (73.11) | 78 (77.23) | 9 (50.00) |